Abstract

McArdle disease is an autosomal recessive disorder caused by the absence of the muscle glycogen phosphorylase, which leads to impairment of glycogen breakdown. The McArdle mouse, a model heavily affected by glycogen accumulation and exercise intolerance, was used to characterize disease progression at three different ages. The molecular and histopathological consequences of the disease were analyzed in five different hind-limb muscles (soleus, extensor digitorum longus, tibialis anterior, gastrocnemius and quadriceps) of young (8-week-old), adult (35-week-old) and old (70-week-old) mice. We found that McArdle mice have a high perinatal and post-weaning mortality. We also observed a progressive muscle degeneration, fibrosis and inflammation process that was not associated with an increase in muscle glycogen content during aging. Additionally, this progressive degeneration varied among muscle and fiber types. Finally, the lack of glycogen content increase was associated with the inactivation of glycogen synthase and not with compensatory expression of the Pygl and/or Pygb genes in mature muscle.

Details

Title
Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model
Author
Real-Martinez, Alberto 1 ; Brull Astrid 2 ; Huerta Jordi 1 ; Tarrasó Guillermo 1 ; Lucia, Alejandro 3 ; Martin Miguel Angel 4   VIAFID ORCID Logo  ; Arenas Joaquin 4 ; Andreu, Antoni L 5 ; Nogales-Gadea Gisela 6 ; Vissing, John 7 ; Krag, Thomas O 7   VIAFID ORCID Logo  ; de Luna Noemi 8 ; Pinós Tomàs 5 

 Mitochondrial and Neuromuscular Disorders Unit, Vall d’Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain (GRID:grid.7080.f) 
 Sorbonne Université, INSERM UMRS_974, Center of Research in Myology, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657) 
 Universidad Europea de Madrid, Faculty of Sport Sciences, Madrid, Spain (GRID:grid.119375.8) (ISNI:0000000121738416); 12 de Octubre Hospital Research Institute (i+ 12), Mitochondrial and Neuromuscular Diseases Laboratory, Madrid, Spain (GRID:grid.144756.5) (ISNI:0000 0001 1945 5329); Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain (GRID:grid.452372.5) (ISNI:0000 0004 1791 1185) 
 12 de Octubre Hospital Research Institute (i+ 12), Mitochondrial and Neuromuscular Diseases Laboratory, Madrid, Spain (GRID:grid.144756.5) (ISNI:0000 0001 1945 5329); Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain (GRID:grid.452372.5) (ISNI:0000 0004 1791 1185) 
 Mitochondrial and Neuromuscular Disorders Unit, Vall d’Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain (GRID:grid.7080.f); Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain (GRID:grid.452372.5) (ISNI:0000 0004 1791 1185) 
 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain (GRID:grid.452372.5) (ISNI:0000 0004 1791 1185); Universitat Autònoma de Barcelona, Grup de Recerca en Malalties Neuromusculars i Neuropediàtriques, Department of Neurosciences, Institut d’Investigacio en Ciencies de la Salut Germans Trias i Pujol i Campus Can Ruti, Badalona, Spain (GRID:grid.7080.f) 
 University of Copenhagen, Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
 Universitat Autònoma de Barcelona, Laboratori de Malalties Neuromusculars, Institut de Recerca Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (GRID:grid.7080.f); Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain (GRID:grid.452372.5) (ISNI:0000 0004 1791 1185) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2197883138
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.